Taking into account, that depending on cell type and environmental conditions exposure of cancer cells to CDDP may affect HSPA1 expression in a highly variable manner, a constant level of HSPA1 in CDDP-treated NSCLC cells is not an unusual observation10. The gene discussed is HSPA1B; the disease is non-small cell lung carcinoma.